- Home
- AGAE vs INKT Comparison
AGAE vs INKT Comparison
Compare AGAE & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AGAE | INKT |
|---|---|---|
| Founded | 2017 | 2017 |
| Country | United States | United States |
| Employees | 73 | N/A |
| Industry | Cable & Other Pay Television Services | Medicinal Chemicals and Botanical Products |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.3M | 53.1M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | AGAE | INKT |
|---|---|---|
| Price | $0.28 | $11.61 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | ★ 233.8K | 186.9K |
| Earning Date | 11-19-2025 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.25 | $6.66 |
| 52 Week High | $3.79 | $76.00 |
Technical Indicators
Market Signals| Indicator | AGAE | INKT |
|---|---|---|
| Relative Strength Index (RSI) | 46.30 | 57.92 |
| Support Level | $0.27 | $10.94 |
| Resistance Level | $0.33 | $11.65 |
| Average True Range (ATR) | 0.03 | 0.96 |
| MACD | 0.00 | 0.26 |
| Stochastic Oscillator | 36.74 | 75.91 |
Price Performance
Historical ComparisonAbout AGAE Allied Gaming & Entertainment Inc.
Allied Gaming & Entertainment Inc is an experiential entertainment company focused on providing a growing world of gamers with various experiences through renowned assets, products, and services.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.